poloxalene has been researched along with Smallpox in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berhanu, A; Brown, LL; Grosenbach, DW; Honeychurch, KM; Hruby, DE; Jones, KF; King, DS; Kirkwood-Watts, DL; Krupkin, AK; Lund, SA; Vandermay, E; Warren, TK; Weimers, W; Wilson, RL | 1 |
1 other study(ies) available for poloxalene and Smallpox
| Article | Year |
|---|---|
Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Cord Factors; Epitopes, B-Lymphocyte; Escherichia coli; Female; Humans; Interferon-gamma; Lipid A; Lymphocytes; Membrane Glycoproteins; Membrane Proteins; Mice; Mice, Inbred BALB C; Neutralization Tests; Poloxalene; Smallpox; Smallpox Vaccine; Spleen; Survival Analysis; Vaccines, Subunit; Vaccinia virus; Viral Envelope Proteins; Viral Proteins; Viral Structural Proteins | 2008 |